Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ter Arkh ; 91(2): 16-24, 2019 Feb 15.
Artigo em Russo | MEDLINE | ID: mdl-32598623

RESUMO

The multicenter prospective observational study initiated by the European Helicobacter and Microbiota Study Group (EHMSG) is conducted in 27 countries in Europe. The data from the Russian part of the European registry for the management of Helicobacter pylori infection (European Registry on the management of Helicobacter pylori infection, protocol: "Hp-EuReg") allows us to analyze the real clinical practice of diagnosis and treatment of H. pylori and compare it with international recommendations. MATERIALS AND METHODS: A comparative analysis of the data entered in the register by the Russian research centers "Hp-EuReg", in the period from 2013 to 2018, was conducted. RESULTS AND DISCUSSION: Invasive diagnostic methods prevail for the primary diagnosis of H. pylori [histology - 20.3% (in 2013 year) - 43.9% (in 2018 year), rapid urease test - 31.7% and 47.8% respectively]. The most popular mode of eradication therapy is a 10-day triple therapy (62.8-76.2%), the effectiveness of which does not exceed 79% (per protocol). Invasive tests (histology) are the leading method for control the effectiveness of therapy, however, there is a tendency towards a wider use of non-invasive methods (H. pylori stool antigen - from 17% in 2013 to 29.3% in 2018 and urea breath test from 6.9 to 18.3%, respectively). Serological test to control the effectiveness of eradication is still used from 8.2% (2013) to 6.1% (2018). Eradication therapy was not performed in 28% of patients throughout the entire observation period. CONCLUSION: In Russia, despite approved domestic and international recommendations, deviations in clinical practice persist, both during eradication therapy and in monitoring the effectiveness of eradication therapy.


Assuntos
Antibacterianos/uso terapêutico , Antiulcerosos/uso terapêutico , Antígenos de Bactérias/análise , Testes Respiratórios/métodos , Quimioterapia Combinada/métodos , Fezes/microbiologia , Infecções por Helicobacter/diagnóstico , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori/isolamento & purificação , Antibacterianos/administração & dosagem , Antiulcerosos/administração & dosagem , Quimioterapia Combinada/efeitos adversos , Europa (Continente) , Infecções por Helicobacter/epidemiologia , Helicobacter pylori/imunologia , Humanos , Estudos Prospectivos , Sistema de Registros , Federação Russa/epidemiologia
2.
Ter Arkh ; 90(2): 35-42, 2018 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-30701770

RESUMO

AIM: European Registry on the management of Helicobacter pylori infection («Hp-EuReg¼) - a multicenter prospective observational study initiated by the European Helicobacter and Microbiota Study Group, conducted in 27 European countries in order to evaluate the real clinical practice of diagnosis and treatment of H. pylori and its comparison with international recommendations. MATERIALS AND METHODS: The analysis of 2360 patients entered in the register by the Russian centres of «Hp-EuReg¼ in 2013-2017, who were underwent 1st line eradication therapy. RESULTS: The most common methods of primary diagnosis of H. pylori are histological (37.7%), rapid urease test (29.2%) and serology (29.7%). The duration of eradication therapy in 9.4% of cases was 7 days, in 65.3% - 10 days, and in 25.3% - 14 days. To control the effec- tiveness of treatment, H. pylori antigen in feces (31.3%), urea breath test (23.4%) and histological method (23.3%) were used. In 3.6% cases was used serology by mistake. In 17.3% of patients control was not carried out. The effectiveness of triple therapy with a PPI, amoxicillin, clar- ithromycin (per protocol) was 67.6%, with 7-day course, 81.1% at 10-day and 86.7% at 14-day course. Eradication rate of triple therapy with addition of bismuth (per protocol) reached 90,6% in the group receiving 10-day scheme and 93.6% in the group receiving the 14-day treatment. CONCLUSION: Significant deviations of clinical practice from expert recommendations, most pronounced at the stage of monitoring the effectiveness of therapy, were noted. The suboptimal efficacy of triple therapy is shown.


Assuntos
Antibacterianos , Infecções por Helicobacter , Inibidores da Bomba de Prótons , Amoxicilina/uso terapêutico , Antibacterianos/uso terapêutico , Claritromicina , Quimioterapia Combinada , Europa (Continente) , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori , Humanos , Estudos Prospectivos , Inibidores da Bomba de Prótons/uso terapêutico , Sistema de Registros
3.
Eksp Klin Gastroenterol ; (2): 60-3, 2015.
Artigo em Russo | MEDLINE | ID: mdl-25993875

RESUMO

The review describes the basic strategy of eosinophilic esophagitis diet therapy in adult patients: elemental diet, allergy testing-directed food elimination diet and empirical elimination diet. The review includes information about the effects of different methods of diet therapy on the severity of eosinophilic infiltration of the esophageal mucosa and symptoms of eosinophilic esophagitis.


Assuntos
Esofagite Eosinofílica/dietoterapia , Adulto , Esofagite Eosinofílica/diagnóstico , Esofagite Eosinofílica/patologia , Eosinófilos/patologia , Esôfago/patologia , Hipersensibilidade Alimentar/diagnóstico , Hipersensibilidade Alimentar/patologia , Hipersensibilidade Alimentar/prevenção & controle , Humanos , Mucosa/patologia
4.
Eksp Klin Gastroenterol ; (6): 4-10, 2015.
Artigo em Russo | MEDLINE | ID: mdl-26817098

RESUMO

The typical features of patients with gastroenterology pathology, which have no nosological specificity were analysed: initially chronic course of diseases, combination of diseases, personal features with prevalence of depressions and frustration, an allergization, increase in frequency of a metabolic syndrome and a chronic focal infection.


Assuntos
Gastroenteropatias/patologia , Gastroenteropatias/fisiopatologia , Gastroenteropatias/terapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Doença Crônica , Feminino , Humanos , Infecções/patologia , Infecções/fisiopatologia , Infecções/terapia , Masculino , Síndrome Metabólica/patologia , Síndrome Metabólica/fisiopatologia , Síndrome Metabólica/terapia , Pessoa de Meia-Idade
5.
Gig Sanit ; (3): 32-5, 2006.
Artigo em Russo | MEDLINE | ID: mdl-16808401

RESUMO

Professionally significant functions (visual acuity, color vision and its parameters, and dark adaptation and its parameters) were determined in moderate and severe myopia before and after its excimer laser correction by the LASIK method: in early (1, 3 months) and late (6, 12 months) periods after surgery to decide where the operated persons are allowed to have the jobs associated with railway traffic safety. Sixty-one patients with moderate and severe myopia and 23 control individuals were examined at the Moscow Research and Technological Complex "Eye Surgery". The examinations have demonstrated that the values of visual acuity, color vision, and dark adaptation considerably improved. Whether the persons undergone excimer laser myopia correction are allowed to have the jobs associated with railway transport safety should be individually decided, by taking into account the postoperative recovery of professionally significant visual functions.


Assuntos
Percepção de Cores/fisiologia , Adaptação à Escuridão/fisiologia , Avaliação da Deficiência , Ceratomileuse Assistida por Excimer Laser In Situ , Miopia/reabilitação , Saúde Ocupacional , Acuidade Visual/fisiologia , Adolescente , Adulto , Feminino , Seguimentos , Humanos , Masculino , Miopia/fisiopatologia , Miopia/cirurgia , Prognóstico
6.
Klin Med (Mosk) ; 84(1): 34-7, 2006.
Artigo em Russo | MEDLINE | ID: mdl-16512394

RESUMO

Four hundred patients with bronchial asthma (BA) were questioned. Complex clinical and instrumental examination of 60 patients with BA and endoscopic-positive gastroesophageal reflux disease was carried out; the control groups included 30 patients with BA alone and 30 patients with GERD alone. Clinical symptoms of GERD were revealed in 58% of BA patients; endoscopic-positive GERD was diagnosed in 48.6% of BA patients. The study proved the connection between the degree of respiratory disturbances, on the one hand, and the degree of esophagitis and the level of intraesophageal pH, on the other, in patients with BA plus GERD. The study also established the role of esophageal and gastric epitheliocytes, producing endothelin-1, melatonin, NO-synthase, and calretinin, in the occurrence of mutual exacerbation syndrome.


Assuntos
Asma/complicações , Esôfago/patologia , Refluxo Gastroesofágico/complicações , Refluxo Gastroesofágico/patologia , Estômago/patologia , Adulto , Algoritmos , Asma/enzimologia , Calbindina 2 , Endotelina-1/metabolismo , Esôfago/enzimologia , Feminino , Refluxo Gastroesofágico/enzimologia , Humanos , Masculino , Melatonina/metabolismo , Óxido Nítrico Sintase/metabolismo , Proteína G de Ligação ao Cálcio S100/metabolismo , Índice de Gravidade de Doença , Estômago/enzimologia
7.
Klin Med (Mosk) ; 83(7): 52-5, 2005.
Artigo em Russo | MEDLINE | ID: mdl-16117427

RESUMO

The aim of the study was to determine microorganism-associated predictors of efficacy of eradication therapy in patients with Helicobacter pylori-associated duodenal ulcer. The subjects were 129 such patients. Clinical, endoscopic, microbiological, and immunological examination revealed differences in the initial immune status, the structure of gastroduodenal zone mucosa, and large bowel biocenosis, which predict efficacy of eradication therapy.


Assuntos
Antiulcerosos/uso terapêutico , Úlcera Duodenal/tratamento farmacológico , Antibacterianos/uso terapêutico , Anticorpos Antibacterianos/imunologia , Autoanticorpos/sangue , Quimioterapia Combinada , Úlcera Duodenal/imunologia , Úlcera Duodenal/patologia , Duodenoscopia , Seguimentos , Infecções por Helicobacter/tratamento farmacológico , Infecções por Helicobacter/imunologia , Infecções por Helicobacter/patologia , Helicobacter pylori/imunologia , Helicobacter pylori/isolamento & purificação , Humanos , Imunoglobulinas/sangue , Mucosa Intestinal/microbiologia , Mucosa Intestinal/patologia , Estudos Retrospectivos , Linfócitos T/imunologia , Linfócitos T/patologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...